Upcoming Cell Webinars

Presented by expert speakers from leading pharmaceutical companies, research institutions, and vendor corporations, these webinars provide an interactive insight into novel tools and technologies for more intensive and reliable cell & gene therapy manufacture, including automation and scale-down techniques, strategies to overcome process bottlenecks, the navigation of regulatory hurdles, and more.

Can’t make the date? Register to receive a recording of the event.

13 Nov 2023
Mon, 13 November 2023

Accelerating Innovation Across Cell Therapies, Viral Vectors, Oligonucleotides and mRNA Delivery Workshop

Presented by Reni Kitte, Research Associate, PhD Candidate, Fraunhofer Institute for Cell Therapy and Immunology IZI (Fraunhofer IZI)
Margherita Neri, Vector Process Development Director, AGC Biologics
Dr. Barrie Cassey, Technology Lead – MMIC, Dr. Claire MacLeod, Grand Challenge Lead – Oligo Manufacturing at CPI
Dr. Maribel Lara Chica, Head of Manufacturing of the Lentiviral Vector Platform for CAR-T Cell Therapy / Postdoctoral Research Scientist at IBiS

Oxford Global | Cytiva

Webinar Recordings

Miss the webinar? All of our past webinar recordings are available to watch below.

Filter by Subject Area

Cell Series – Subject

Search by Keyword

Hosted by Ryan Cawood, Chief Scientific Officer, Oxgene/ Wuxi Advanced Therapeutics
14 October 2021
Presented by Krzysztof Inglot, Technical Sales Specialist, Thermo Fisher Scientific | Femi Egbebi, Senior Global Product Manager, Thermo Fisher Scientific | Daniel Merriman, Strategic Marketing Manager, Thermo Fisher Scientific
23 September 2021
Moderated by Jim McNally, Chief Scientific Officer, BioAgilytix Presented by Jennifer T. Durham, Associate Director of Scientific Services, BioAgilytix | Jeff Patrick, Director of GMP Operations, BioAgilytix | Terran Pierfelice, Business Head, Gene Therapy, Resilience | Nathan Rudemiller, Manager II, BioAgilytix | Thomas J. Schneider, Associate Director of Scientific Servicesm, BioAgilytix
22 September 2021
Presented by Erin Cross, Associate Director of Whole Genome R&D, KromaTid & Chris Tompkins, Chief Technology Officer, KromaTid
08 September 2021